VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Gilead Sciences, Inc. (GILD) Total Return Calculator with Dividends Reinvested

Gilead Sciences, Inc.

Popular:

The total return for Gilead Sciences, Inc. (GILD) stock is +42.51% over the past 12 months. So far it's up 12.76% this year. The 5-year total return is +127.55%, meaning $10,000 invested in GILD stock 5 years ago would be worth $22,755 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in GILD 1 year ago, it would be worth $14,150 today — you'd have gained $4,150 with dividends reinvested.

With Dividends Reinvested$14,150+41.50%

Price Only (No DRIP)$13,782+37.82%

Dividend Boost+$3684 payments · +3.68% extra

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

Dividends

S&P 500

If You Invested $10,000 in GILD

1Y$14,251+$4,251 (+42.5%)42.5% CAGR

3Y$18,528+$8,528 (+85.3%)22.8% CAGR

5Y$22,755+$12,755 (+127.5%)17.9% CAGR

10Y$19,264+$9,264 (+92.6%)6.8% CAGR

15Y$80,414+$70,414 (+704.1%)14.9% CAGR

20Y$116,666+$106,666 (+1066.7%)13.1% CAGR

30Y$1.73M+$1.72M (+17196.1%)18.7% CAGR

Dividend Reinvestment History (4)▲ Hide

Ex-Date	Dividend	Reinvest Price	Shares Added
2025-06-13	$0.79	$109.98	+0.007183
2025-09-15	$0.79	$112.54	+0.007070
2025-12-15	$0.79	$119.78	+0.006689
2026-03-13	$0.82	$144.99	+0.005774

Loading GILD total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+12.76%	—	+12.09%	+0.67 pp	$11,276
1Y	+42.51%	42.51%	+39.25%	+3.26 pp	$14,251
3Y	+85.28%	22.82%	+73.43%	+11.85 pp	$18,528
5Y	+127.55%	17.87%	+104.84%	+22.71 pp	$22,755
10Y	+92.64%	6.78%	+60.96%	+31.68 pp	$19,264
15Y	+704.14%	14.91%	+564.87%	+139.27 pp	$80,414
20Y	+1066.66%	13.07%	+864.61%	+202.05 pp	$116,666
30Y	+17196.15%	18.74%	+14200.66%	+2995.49 pp	$1.73M

Risk & Highlights

Best Year+124.57%1995

Worst Year-25.06%2016

Max Drawdown-18.00%2026-02-11 → 2026-04-27

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+23.17%	+22.49%	+0.7pp	+0.41%	+22.8pp
2025	+37.03%	+33.59%	+3.4pp	+16.64%	+20.4pp
2024	+14.67%	+10.97%	+3.7pp	+24.00%	-9.3pp
2023	-1.62%	-5.13%	+3.5pp	+24.81%	-26.4pp
2022	+22.31%	+18.28%	+4.0pp	-19.95%	+42.3pp

GILD outperformed the S&P 500 by 11.19pp over the past year (+42.51% vs +31.32%).

Loading summary...

GILD Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
GILDGilead Sciences, Inc.	$169.8B	-2.7%	+12.8%	+42.5%	+3.3pp	+85.3%	+127.5%	+92.6%
ABBVAbbVie Inc.	$362.6B	-0.8%	-9.1%	+13.1%	+3.6pp	+52.0%	+102.8%	+306.7%
BMYBristol-Myers Squibb Company	$115.4B	-4.7%	+8.1%	+24.1%	+5.3pp	-6.7%	+5.6%	+7.3%
AMGNAmgen Inc.	$178.7B	-3.3%	+1.8%	+26.0%	+3.6pp	+52.8%	+48.7%	+161.5%
BIIBBiogen Inc.	$28.2B	+10.6%	+7.2%	+63.2%	—	-39.3%	-29.9%	-27.7%
REGNRegeneron Pharmaceuticals, Inc.	$74.9B	-5.5%	-7.0%	+29.7%	+0.6pp	-3.6%	+45.4%	+96.0%
VRTXVertex Pharmaceuticals Incorporated	$108.8B	-1.5%	-5.4%	-5.0%	—	+24.3%	+100.6%	+399.9%
MRKMerck & Co., Inc.	$280.5B	-6.1%	+7.5%	+47.9%	+4.2pp	+3.9%	+73.3%	+171.4%
PFEPfizer Inc.	$150.8B	-4.8%	+7.0%	+23.4%	+7.5pp	-18.4%	-11.3%	+30.7%
JNJJohnson & Johnson	$541.3B	-6.8%	+9.0%	+48.8%	+3.4pp	+47.6%	+48.0%	+136.2%
INCYIncyte Corporation	$19.9B	+5.3%	-1.5%	+67.5%	—	+51.8%	+21.3%	+41.3%

Compare:GILD vs ABBV GILD vs BMY GILD vs AMGN GILD vs ABBV vs BMY

About GILD Dividend Returns

Gilead Sciences, Inc. (GILD) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of GILD over the past year?

Gilead Sciences, Inc. (GILD) delivered a total return of 42.51% over the past year when dividends are reinvested. The price-only return was 39.25%, meaning dividends contributed an additional 3.26 percentage points to total returns.

Q2How much would $10,000 invested in GILD be worth today?

A $10,000 investment in Gilead Sciences, Inc. one year ago would be worth $14,251 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $13,925. Dividend reinvestment added $326 to the portfolio value.

Q3Does GILD pay dividends?

Yes, Gilead Sciences, Inc. (GILD) pays dividends. In the last year, GILD paid approximately $3.12 per share in dividends (2.29% yield). Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.

Q4Did GILD beat the S&P 500?

Yes, Gilead Sciences, Inc. (GILD) outperformed the S&P 500 by 11.19 percentage points over the past year. GILD delivered a total return of 42.51%, compared to the S&P 500's 31.32%. This 11.19pp alpha means investors in GILD earned more than a passive S&P 500 index fund.

Q5What is GILD's worst drawdown?

Gilead Sciences, Inc. (GILD) experienced a maximum drawdown of -18.00% over the past year, declining from its peak on 2026-02-11 to its trough on 2026-04-27. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is GILD's long-term total return over 10, 20, or 30 years?

Here are Gilead Sciences, Inc. (GILD)'s long-term returns with dividends reinvested. Over 10 years, the total return is 92.6% (6.8% CAGR) — $10,000 would have grown to $19,264. Over 20 years: 1066.7% total return (13.1% CAGR) — $10,000 → $116,666. Over 30 years: 17196.1% total return (18.7% CAGR) — $10,000 → $1.73M. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was GILD's best and worst year?

Gilead Sciences, Inc.'s best calendar year was 1995 with a total return of 124.6%. Its worst year was 2016 with a total return of -25.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 149.6 percentage points.